4-Methyl-2-(3,4-dichlorophenyl)thiazole-5-carboxylic acid, 95+%, 1g

(4-Iodopyridin-2-yl)methanol, 95%, 100mg

1-Cyclopropyl-2-(2-fluoro-phenyl)-ethanone, 95.0%, 25g

2-cyclohexanecarbonyl-1H,2H,3H,4H,6H,7H,11bH-piperazino[2,1-a]isoquinolin-4-one, 98.0%, 25g

Naphthalene-1,4,5,8-tetracarboxylic acid, contains Monoanhydride, 60.0%, 5g

1-Methyl L-Aspartate>98.0%(T)5g

6-methoxy-1H,4H-pyrido[3,4-d]pyrimidin-4-one, 98%, 100mg

S-Methyl Thiopropionate>98.0%(GC)25g

3-((Trimethylsilyl)ethynyl)aniline, 95.0%, 250mg

(2-phenyl-1-benzofuran-5-yl)amine, 95.0%, 5g

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 5.00 µm, 1 Piece(s)

6-Ethoxy-4-methylpyridin-3-amine, 95+%, 50mg

3',6'-Bis(dimethylamino)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid, 98%, 100mg